Influenza Vaccine in Children With Asthma
NCT04086628 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2019-12-17
Summary
The occurence of influenza can be a factor of imbalance of asthma. Asthma patients are recommended for annual influenza vaccination . However there is insufficient vaccination coverage of asthmatic patients despite this recommendation. The aim of this study is to evaluate the rate of influenza vaccination coverage of children with asthma aged from 6 month to 17 years of age followed in pediatric pneumology consultation at the university hospital of Nancy.
Conditions
- Asthma in Children
- Influenza Vaccine
- Immunization Coverage
Sponsors & Collaborators
-
Central Hospital, Nancy, France
lead OTHER
Principal Investigators
-
Aurore Blondé, Dr · CHRU nancy
Eligibility
- Min Age
- 6 Months
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-11-04
- Primary Completion
- 2020-04-30
- Completion
- 2020-04-30
Countries
- France
Study Locations
More Related Trials
-
Development of Childhood Anti-Influenza Immunity
NCT03673345 ·Status: COMPLETED ·Phase: PHASE4
-
Influenza Vaccine Effectiveness in Among Young Children in Taiwan
NCT06446232 ·Status: RECRUITING
-
Influenza Immunity in Children
NCT02559505 ·Status: COMPLETED ·Phase: NA
-
Direct and Indirect Benefits of Influenza Vaccine Versus Placebo in Healthy Children
NCT00792051 ·Status: COMPLETED ·Phase: NA
-
In-depth Analysis of the Immune Responses in the Upper Respiratory Tract of Influenza-infected Children
NCT06998264 ·Status: RECRUITING
-
Safety of Nasal Influenza Immunisation in Children With Asthma
NCT02866942 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity of Inactivated Influenza Virus Vaccine Among Healthy Children 6-12 Weeks of Age
NCT00242424 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety of Nasal Influenza Immunisation in Egg Allergic Children
NCT01859039 ·Status: COMPLETED
-
Immunogenicity and Safety Following a Single Dose of Influenza Vaccines in Healthy Children Who Received Either One or the Other Vaccine (an Adjuvanted Sub-unit Influenza Vaccine and a Non-adjuvanted Split Virion Influenza Vaccine) in the Previous V70P2 Study
NCT00644540 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of 2 Commercially Available Influenza Vaccines in Children
NCT00408395 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Influenza Vaccination of Healthcare Workers (HCW) on the Risk of Influenza in Patients Hospitalized in Short Stays Units
NCT02198638 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Pediatric Populations
NCT02100436 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Tolerance to a Live Attenuated Vaccine Against Influenza (Flumist®) in a Population Allergic to Eggs
NCT02142491 ·Status: COMPLETED
-
Comparison of Inactivated and Live, Attenuated Influenza Vaccine in Children 5-9 Years of Age-Year 3 Amendment
NCT00138385 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Trial of an Quadrivalent Inactivated Influenza Vaccine in Healthy Children Aged 6 to 35 Months
NCT05212623 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Describe Pediatric Influenza Vaccine Coverage
NCT00639418 ·Status: COMPLETED
-
Influenza Vaccine Safety and Effectiveness in Healthcare Providers
NCT01282177 ·Status: COMPLETED
-
Influenza Vaccine in Premature Infants
NCT00455169 ·Status: COMPLETED
-
A Post Marketing Evaluation of the Effectiveness of FluMist Risk Minimization Plan in Children
NCT00626808 ·Status: COMPLETED
-
Feasibility of Cocooning Immunization Strategy With Influenza Vaccine
NCT00570037 ·Status: COMPLETED ·Phase: NA
-
Effect of Age and Prior Immunity to Response to Seasonal Influenza Vaccines in Children
NCT01246999 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11
NCT01206114 ·Status: COMPLETED
-
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
NCT01992107 ·Status: COMPLETED ·Phase: PHASE3
-
Study on the Immunogenicity and Tolerability of Influsplit SSW® 2005/2006 in Children Aged 6 - 13 Years
NCT00372255 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity of One Dose of a Surface, Antigen, Inactivated, Influenza Vaccine Produced in Mammalian Cell Culture Administered to Adult and Elderly Subjects
NCT01422512 ·Status: COMPLETED ·Phase: PHASE3